132487-Thumbnail Image.png
Description

Fusion protein immunotherapies such as the bispecific T cell engager (BiTE) have displayed promising potential as cancer treatments capable of engaging the immune system against tumor cells.

1.36 MB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
2019-05
Resource Type
  • Text
  • Machine-readable links